Advisors Inner Circle Fund III
GQGG · NYSE Arca · ETF
GQGG key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 162.25K
- Volume
- 102.76K
- Open price
- $24.25
- High today
- $24.25
- Low today
- $23.22
- 52 Week high
- $25.37
- 52 Week low
- $24.43
Advisors Inner Circle Fund III (GQGG) at a glance
As of Nov 20, 2026, Advisors Inner Circle Fund III (GQGG) shares are priced at $23.22, giving the company a price-to-earnings ratio of 0.00.
On Nov 20, 2026, the fund traded between $23.22 and $24.25. Its last price was 0.0% above the day's low and 4.2% below its high.
Volume on Nov 20, 2026 reached 102.76K shares, below the average of 162.25K shares a day.
Over the past year Advisors Inner Circle Fund III has ranged from $24.43 to $25.37, and now sits -127% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- HIRUHiru$0.0004+0.00%
- NVDANVIDIA$125.84−13.80%
- SOXLDirexion Shares ETF Trust$30.88−31.84%
- ANTAnthropic PBC$88.30−9.13%
- NXATNexus Advanced Technologies$0.548+144.97%
- SPDNDirexion Shares ETF Trust$9.41+3.63%
- NIVFNewGenIvf Group$0.0269−23.14%
- TQQQProShares Trust$41.01−16.32%
- AEFIAmerican EcoFuels$0.0005−16.67%
- SNXXTradr 2X Long SNDK Daily ETF$1.76−31.52%
- AITXArtificial Intelligence Technology Solutions$0.0003−16.67%
Newly listed
Companies that went public in the past six weeks
- WWBWINDWARD BIO GROUP AG$24.29+1.15%
- VVVVvVARDIS Holding AG$14.55−3.00%
- MDRNModern Mining Technology$2.85+21.28%
- NARANarragansett Bancorp$10.07−0.69%
- ASPEAspen Neuroscience$12.56+1.37%
- BBTXBambusa Therapeutics$16.00+2.89%
- GBCGEORGIA BANKING$34.25+0.91%
- BHAIUBHAV Acquisition Corp II$10.04+0.20%
- SCQCUSPACCircle Acquisition$10.02+0.10%
- LYCALycia Therapeutics$33.07+4.09%
- DAVIDAVION HEALTHCARE$0.9001−9.99%
- TCXBTCGX Acquisition Corp. II$10.21−1.83%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.